🐻
private access only
incorrect password
early investor access

sleep is a
$100 billion
problem.

We built a gummy bear that actually helps. We're inviting a small number of angels to come along for the ride.

express interest see the terms
scroll
$1.5m valuation cap 20% discount $200k raise ~83% gross margin made in the usa pre-revenue 3–5 angels $1.5m valuation cap 20% discount $200k raise ~83% gross margin made in the usa pre-revenue 3–5 angels $1.5m valuation cap 20% discount $200k raise ~83% gross margin made in the usa pre-revenue 3–5 angels
the unit economics
$4.91 cost to make one bottle at scale. 60 gummies, GMP certified, manufactured in the USA.
$29 retail price launch price. headroom to $34 once reviews are established.
~83% gross margin at scale before fulfilment and customer acquisition cost. Strong for a physical CPG product.
<$4 COGS target clear route to sub-$4/unit at volume. every dollar off cost goes straight to margin.
the pitch
What is snüze?

A sleep gummy. 2mg melatonin micro-dose, passiflora extract, vitamin B6. Passion fruit flavour. Two before bed. That's the routine.

Wind-down bears. The domain is snuze.com. The brand is built. The product is manufactured, GMP certified, and ready to ship.

Why does the distribution matter?

Most CPG startups burn their raise on paid acquisition at negative margin trying to find customers. We already have them.

Moongreens is a live sleep supplement brand with paying customers and active ad spend. snüze launches as a cross-sell at checkout — the highest-intent audience available. No cold acquisition needed to prove the model.

The customer acquisition problem is largely solved before we spend a dollar on snüze-specific ads.

What's the domain worth?

snuze.com was acquired for $15,000. In the sleep and wellness category, a one-word, intuitive, exact-match .com is a genuine strategic asset. Third-party domain valuation tools consistently place it above $200,000 — though no formal independent appraisal has been commissioned.

That asset sits in the entity investors would hold a stake in. It is not on the balance sheet of the parent company.

Who's building this?

James Higgins. ACA-qualified accountant, former banker, serial D2C founder with a prior exit. Now running Midnight Atlas Inc. — a Delaware C-Corp and the holding company behind Moongreens, a live sleep supplement brand with paying customers and active US operations.

snüze is its own ring-fenced entity. Investors hold a stake in the gummy brand, not the wider portfolio.

What does the money do?

Inventory, creative, and early paid acquisition — in that order. At $4.91 COGS this is a low-cost business to validate. The raise accelerates the timeline and gets the right people around the table early.

$200k maximum, from 3–5 angels. This isn't a crowdfund. Access to this page is by referral only.

deal terms

Simple. No drama.

instrument SAFE Simple Agreement for Future Equity. Standard YC template. Converts at next priced round or qualifying liquidity event.
valuation cap $1.5m Pre-money. Shares convert at the lower of this cap or the price in the next priced round.
discount 20% Applied at conversion. You receive shares at 80% of the price paid by the next institutional investor.
raise size $200k Hard cap. Small, intentional group — 3 to 5 angels only.
min ticket $25k Minimum to participate. Preferred ticket size $50–100k.
entity LLC snüze is a standalone Delaware LLC, wholly separate from Moongreens and Midnight Atlas Inc. Entity formation in progress.

interested?
say hello.

No deck, no pitch call required upfront. Send a note and we'll take it from there.

james@moongreens.com

This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any securities offering will be conducted in compliance with applicable US securities laws and will be available only to verified accredited investors as defined under Rule 501 of Regulation D. Investment in early-stage companies involves significant risk, including the possible loss of your entire investment. No return is guaranteed. Past performance of related entities is not indicative of future results. This offering has not been registered with the SEC under the Securities Act of 1933. Midnight Atlas Inc. is a Delaware C-corporation. snüze LLC is a separate entity whose formation is in progress. Nothing on this page creates a binding obligation of any kind.